Latest news with #AjantaPharma
Time of India
13-05-2025
- Business
- Time of India
Pharma Cos Slip on US Move to Cut Prices
HighlightsSeveral pharmaceutical shares, including Sun Pharmaceuticals and Ajanta Pharma, underperformed on a day when the broader market saw a nearly 4 percent rally, following President Donald Trump's announcement of plans to cut US prescription drug prices by 30 to 80 percent. The Nifty Pharma Index, despite a 0.2 percent increase on the day, is down 10 percent year-to-date, contrasting with a 5 percent gain in the benchmark Nifty Index. Analysts suggest that while the proposed executive order primarily affects the branded drugs segment, which comprises 90 percent of the US market, Indian pharmaceutical companies mainly operate in the generics market, thus facing limited risks from these changes. Several pharmaceutical shares underperformed on Monday despite a strong broad market rally, after US President Donald Trump announced plans to sign an executive order slashing prescription drug prices in the US to match those in favoured nations, implying cuts of 30 per cent to 80 per cent. Sun Pharmaceuticals fell 3.2 per cent, Ajanta Pharma slipped 2.3 per cent, and Glenmark and Divi's Labs lost over 1 per cent each. Biocon dipped 0.5 per cent. The Nifty Pharma Index ended 0.2 per cent higher Monday after tumbling almost 2.4 per cent earlier in the day in response to Trump's remarks. The Sensex and Nifty jumped nearly 4 per cent—posting their biggest single-day gains in four years. Of the 20 stocks in Nifty Pharma, 13 gained and seven declined. 'The order implies a 30-80 per cent expected cut to align US drug prices with other regulated markets. But such cuts are commercially unviable for pharma firms, especially those with low-double-digit margins,' said Nikhil Ranka, CIO at Nuvama Alternates. 'That's why companies like Sun Pharma, which derives around 40 per cent revenues from the US, saw declines.' Ranka said most pharma stocks rebounded after an initial knee-jerk reaction, as the proposed changes are not expected to be immediately enforceable or impactful. 'Pharma stocks could resume their uptrend in the coming sessions,' he said. Year-to-date, the Nifty Pharma Index is down 10 per cent, compared with a 5 per cent gain in the benchmark Nifty. Bhavesh Gandhi, lead analyst for pharma and healthcare at YES Securities, said the proposed policy primarily targets the branded drugs segment, which accounts for 90 per cent of the US market. Indian companies cater mostly to the remaining 10 per cent — the generics space — where prices are already low. 'Sun Pharma, with some exposure to the branded segment, may face limited risk. But for now, the reaction is largely sentimental, and the real impact will depend on how earnings shape up,' Gandhi said.
Time of India
13-05-2025
- Business
- Time of India
Pharmaceutical shares decline: Pharma stocks decline amid Trump's prescription drug price cuts announcement
ADVERTISEMENT ADVERTISEMENT Mumbai: Several pharmaceutical shares underperformed on Monday despite a strong broad market rally, after US President Donald Trump announced plans to sign an executive order slashing prescription drug prices in the US to match those in favoured nations, implying cuts of 30% to 80%.Sun Pharmaceuticals fell 3.2%, Ajanta Pharma slipped 2.3%, and Glenmark and Divi's Labs lost over 1% each. Biocon dipped 0.5%.The Nifty Pharma Index ended 0.2% higher Monday after tumbling almost 2.4% earlier in the day in response to Trump's remarks. The Sensex and Nifty jumped nearly 4%-posting their biggest single-day gains in four years. Of the 20 stocks in Nifty Pharma, 13 gained and seven declined."The order implies a 30-80% expected cut to align US drug prices with other regulated markets. But such cuts are commercially unviable for pharma firms, especially those with low-double-digit margins," said Nikhil Ranka, CIO at Nuvama Alternates. "That's why companies like Sun Pharma, which derives around 40% revenues from the US, saw declines."Ranka said most pharma stocks rebounded after an initial knee-jerk reaction, as the proposed changes are not expected to be immediately enforceable or impactful. "Pharma stocks could resume their uptrend in the coming sessions," he the Nifty Pharma Index is down 10%, compared with a 5% gain in the benchmark Gandhi, lead analyst for pharma and healthcare at YES Securities, said the proposed policy primarily targets the branded drugs segment, which accounts for 90% of the US market. Indian companies cater mostly to the remaining 10% - the generics space - where prices are already low."Sun Pharma, with some exposure to the branded segment, may face limited risk. But for now, the reaction is largely sentimental, and the real impact will depend on how earnings shape up," Gandhi Ratings and Research said Trump's executive order to reduce the prices of prescription drugs in the US, once implemented, will have a limited near-term impact on the Indian pharma companies, but it may have a bearing on their long-term capital allocation strategies. Most Indian companies operate on thin margins in the generic drugs segment, which limits scope for further price reductions. The proposed cuts are more likely to target the branded drugs segment, said analysts.'Volumes may remain stable, but lower prices could squeeze margins and weigh on share prices,' said Dharmesh Kant, head of research at Cholamandalam Securities. He expects firms such as Sun Pharma, Aurobindo Pharma, and Cipla to be affected, though the extent of the impact is still uncertain.
Business Standard
02-05-2025
- Business
- Business Standard
Ajanta Pharma consolidated net profit rises 11.12% in the March 2025 quarter
Sales rise 11.04% to Rs 1170.41 crore Net profit of Ajanta Pharma rose 11.12% to Rs 225.26 crore in the quarter ended March 2025 as against Rs 202.72 crore during the previous quarter ended March 2024. Sales rose 11.04% to Rs 1170.41 crore in the quarter ended March 2025 as against Rs 1054.08 crore during the previous quarter ended March 2024. For the full year,net profit rose 12.77% to Rs 920.39 crore in the year ended March 2025 as against Rs 816.17 crore during the previous year ended March 2024. Sales rose 10.44% to Rs 4648.10 crore in the year ended March 2025 as against Rs 4208.71 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 1170.411054.08 11 4648.104208.71 10 OPM % 25.3926.40 - 27.1027.85 - PBDT 309.19312.29 -1 1333.271249.33 7 PBT 269.41278.04 -3 1189.161113.93 7 NP 225.26202.72 11 920.39816.17 13
Time Business News
21-04-2025
- Health
- Time Business News
Kamagra Oral Jelly – A Simple Solution for Erectile Dysfunction
Erectile dysfunction (ED) is a common issue faced by men across the world. Many men feel shy or uncomfortable discussing this condition, but there are effective treatments available that can help restore confidence and improve intimacy. One such popular and reliable solution is Kamagra Oral Jelly, manufactured by mediquickrx In this article, we will discuss everything you need to know about Kamagra Oral Jelly – how it works, its benefits, how to use it, and why it is becoming a preferred choice for men suffering from ED. You will also learn why mediquickrx is the trusted platform to buy Kamagra products safely and discreetly online. Kamagra Oral Jelly is a fast-acting medication used to treat erectile dysfunction in men. It contains Sildenafil Citrate, the same active ingredient found in Viagra. Kamagra helps increase blood flow to the penis during sexual stimulation, which allows men to achieve and maintain a firm erection. The key difference between Kamagra Oral Jelly and regular ED tablets is its jelly form, which makes it easier to swallow and faster to absorb into the bloodstream. It is especially helpful for men who have difficulty swallowing pills. Kamagra Oral Jelly is made by mediquickrx, a well-known pharmaceutical company based in India. Ajanta Pharma is respected globally for producing high-quality medicines at affordable prices. Their Kamagra range is trusted by millions of men for its safety, effectiveness, and quality. The main ingredient in Kamagra Oral Jelly is Sildenafil Citrate, which is a PDE5 inhibitor. This compound works by relaxing the blood vessels in the penis, allowing more blood to flow when a man is sexually aroused. Here's a simple explanation of the process: You consume the jelly. The Sildenafil enters your bloodstream. It helps relax the muscles in your penis. When you're aroused, blood flows more easily, helping you get an erection. It's important to note that Kamagra will not cause an erection on its own – sexual stimulation is still needed for it to work. There are several reasons why men prefer Kamagra Oral Jelly over traditional ED pills: Kamagra Oral Jelly starts working within 15 to 30 minutes, much faster than standard tablets which may take up to an hour. Since it's in jelly form, it's easy to swallow – no need for water or struggling with tablets. Kamagra Oral Jelly comes in various flavours like pineapple, orange, strawberry, banana, vanilla, and more, making the experience more enjoyable. It's packaged in small sachets, so you can carry it discreetly and use it when needed without drawing attention. Compared to branded Viagra, Kamagra offers the same effectiveness at a lower cost – a budget-friendly option for long-term use. Using Kamagra Oral Jelly is simple: Open one sachet and squeeze the jelly into your mouth. Take it 15 to 30 minutes before planned sexual activity. before planned sexual activity. Do not take more than one sachet in 24 hours. It works best on an empty stomach or after a light meal. Avoid alcohol or heavy fatty foods before consumption, as it may delay the effect. Kamagra Oral Jelly is designed for men aged 18 and above who are experiencing erectile dysfunction. However, it is not recommended for: Women or children Men with heart problems Men taking nitrates or blood pressure medications Individuals with liver or kidney issues Always consult a doctor before starting any ED treatment. Like all medicines, Kamagra Oral Jelly may cause some side effects, although not everyone experiences them. Common side effects include: Headache Flushing (redness of the face) Dizziness Upset stomach Nasal congestion Blurred vision Most side effects are mild and go away on their own. But if you experience chest pain, a prolonged erection, or severe dizziness, seek medical help immediately. There are many online platforms selling ED medications, but not all are safe. At mediquickrx, your health and privacy come first. Genuine Products : We sell only 100% authentic Kamagra Oral Jelly directly from Ajanta Pharma . : We sell only 100% directly from . Affordable Prices : Get the best rates and deals on bulk orders. : Get the best rates and deals on bulk orders. Secure Payment Options : Shop with confidence using trusted payment gateways. : Shop with confidence using trusted payment gateways. Fast Delivery : Receive your order discreetly and quickly at your doorstep. : Receive your order discreetly and quickly at your doorstep. Customer Support: Our friendly team is always ready to help you with any questions. At mediquickrx, we believe everyone deserves a healthy and fulfilling intimate life. That's why we provide safe and easy access to effective ED solutions like Kamagra Oral Jelly. Kamagra Oral Jelly can last for 4 to 6 hours after consumption, depending on the individual. It's not recommended to use Kamagra Oral Jelly more than once a day. Consult your doctor if you feel you need to take it daily. Yes, when taken as directed, Kamagra Oral Jelly is safe and effective. But you must consult a doctor if you have any existing health conditions. In many countries, Kamagra Oral Jelly is available without a prescription, but we always recommend consulting a doctor before use. At mediquickrx, we guide you in the safest way possible. Kamagra Oral Jelly by Ajanta Pharma is a powerful, fast, and easy-to-use treatment for erectile dysfunction. Its jelly format, quick action, and delicious flavours make it a top choice among men worldwide. Whether you're looking for a more comfortable way to treat ED or seeking an affordable alternative to Viagra, Kamagra Oral Jelly is a great option. When it comes to buying Kamagra Oral Jelly, trust mediquickrx – your reliable partner for authentic ED medications. We ensure complete privacy, fast shipping, and customer care that supports your wellness journey. Take the first step towards renewed confidence and better intimacy with Kamagra Oral Jelly – because you deserve to enjoy every moment to the fullest. TIME BUSINESS NEWS
